Patients planned for cellular therapy supplementation such as CAR-T or stem cell transplant who are admitted for atleast 7 days in patient. During that time of admission, patients enrolled will complete a once daily, virtual reality guided progressive muscle relaxation program. Various validated QOL tools will be utilized to assess study results.
Able to provide informed consent
Age greater than or equal to 18 years old
Either have a planned admission or already be admitted to the in-patient oncology ward (3NW) with cellular therapy needs.
Able to understand English
Poor performance status of ECOG 3-4
Recent use of immersive VR programs for stress relief and/or entertainment (more than 2 days/week within the past 3 months)
Participation in another stress-reduction type interventional study within the past 3 months
Current or history of seizure, epilepsy, or other known severe neurological or mental health disorders